{"id":"W4410611436","doi":"10.1016/j.esmoop.2025.105110","title":"Efficacy and safety of larotrectinib as first-line treatment for patients with TRK fusion cancer","year":2025,"lang":"en","type":"article","venue":"ESMO Open","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"ca_institutions":"Bayer (Canada)","funders":"National Cancer Institute; Loxo Oncology; Bayer HealthCare; Bayer Corporation; Bayer","keywords":"Trk receptor; Cancer; Line (geometry); Fusion; Medicine; Internal medicine; Neurotrophin","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009839274,0.0002032614,0.0008224589,0.0002414093,0.0001869909,0.0005668084,0.0002437059,0.0004165944,0.002203972],"category_scores_gemma":[0.001245501,0.00009297644,0.0006963731,0.0002366341,0.0001932609,0.0003738877,0.0001858724,0.0008824348,0.000473764],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009901753,"about_ca_system_score_gemma":0.0005859533,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005829911,"about_ca_topic_score_gemma":0.00188184,"domain_scores_codex":[0.9996541,0.0001152674,0.00002887808,0.00005801509,0.0000841382,0.00005970139],"domain_scores_gemma":[0.9992883,0.0002025017,0.0002322978,0.00002939244,0.0000686055,0.0001789585],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.1438692,0.005043603,0.09873252,0.002289749,0.001648529,0.000714247,0.0003512182,0.004160849,0.03310636,0.0003412549,0.01568493,0.6940576],"study_design_scores_gemma":[0.07938824,0.3234064,0.5184553,0.0007893358,0.003059122,0.006637634,0.0003318007,0.006661212,0.02258318,0.0005874113,0.03797859,0.0001217864],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9686159,0.02286723,0.0003683869,0.0007725958,0.00008065411,0.0003429345,0.001456169,0.0001066961,0.005389629],"genre_scores_gemma":[0.9940636,0.002846074,0.0002786203,0.0004972739,0.00007310106,0.0001613804,0.00139139,0.00001133367,0.0006772949],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002203972,"threshold_uncertainty_score":0.007373035,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01762276124513903,"score_gpt":0.3755784067848174,"score_spread":0.3579556455396784,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}